Last reviewed · How we verify
NCT06571279
Assessing the Impact of a Plant-Based Diet for Diabetes Prevention
NA trial testing Plant-based diet in Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) in 9 participants. Completed in 25 November 2025.
25 November 2025
Quick facts
| Lead sponsor | Jean L. Fry |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 9 |
| Start date | 14 October 2024 |
| Primary completion | 25 November 2025 |
| Estimated completion | 25 November 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Plant-based diet
Conditions studied
- Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) — all drugs for Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) →
Sponsor
Jean L. Fry
Who can join
Adults 30 to 55, any sex, with Prediabetes (Insulin Resistance, Impaired Glucose Tolerance). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary purpose of this study is to determine the sex-specific metabolic and molecular response, among adults with prediabetes, when moving from a Western Diet to plant-based diet.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06571279
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Plant-based diet
Trials testing the same drug.
- NCT06186843 — Plant-based Diet for Kidney Transplant Recipients · NA · active not recruiting
- NCT05885828 — The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes · NA · recruiting
- NCT05659966 — Nutritious Eating With Soul Dissemination and Implementation · NA · active not recruiting
- NCT05706649 — A Study of Plant-based Diet on Postprandial Sleepiness · NA · completed
- NCT05231317 — Effect of the Sustainable Diet on Gut Microbiota and the Metabolome: a Randomised Crossover Study · NA · completed
Other recruiting trials for Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Currently open trials in the same condition.
- NCT07286747 — Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT) · Phase 2 · recruiting
- NCT07073781 — Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regul · NA · recruiting
- NCT06723886 — Antidiabetic Effect of Olive Pomace Oil · NA · recruiting
- NCT06697756 — Resistance Training for the Improvement of Glycemic Control in Prediabetes · NA · active not recruiting
- NCT06735651 — Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes · NA · recruiting
Other Jean L. Fry trials
Trials by the same sponsor.
- NCT07329088 — Isoleucine Addition Treatment Effects in a Controlled Diet Study · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06571279 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jean L. Fry
- Last refreshed: 11 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06571279.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing